Immatics N.V. (IMTX) Stock Forecast
Data as of May 3, 2026Healthcare · Current price $10.82 (-1.55%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 19, 2026 | Graig Suvannavejh | Mizuho Securities | $25.00 | +131.1% |
| Dec 4, 2025 | Jonathan Chang | Leerink Partners | $17.00 | +57.1% |
| Oct 29, 2025 | Graig Suvannavejh | Mizuho Securities | $19.00 | +75.6% |
| Sep 17, 2025 | Paul Jeng | Guggenheim | $16.00 | +47.9% |
| May 16, 2024 | Graig Suvannavejh | Mizuho Securities | $16.00 | +47.9% |
| Aug 9, 2022 | Geulah Livshits | Chardan Capital | $28.00 | +158.8% |
Top Analysts Covering IMTX
IMTX vs Sector & Market
| Metric | IMTX | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 3 | 8 | 18 |
| Target Upside | +94.1% | +1150.2% | +14.9% |
| P/E Ratio | -6.61 | 6.87 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $10M | $10M | $10M | 4 |
| 2026-09-30 | $10M | $10M | $10M | 2 |
| 2026-12-31 | $11M | $11M | $11M | 3 |
| 2027-12-31 | $17M | $48M | $80M | 6 |
| 2028-12-31 | $42M | $163M | $298M | 5 |
| 2029-12-31 | $52M | $202M | $369M | 2 |
| 2030-12-31 | $100M | $384M | $702M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-0.41 | $-0.41 | $-0.41 | 4 |
| 2026-09-30 | $-0.42 | $-0.42 | $-0.42 | 1 |
| 2026-12-31 | $-0.40 | $-0.40 | $-0.40 | 2 |
| 2027-12-31 | $-1.66 | $-1.56 | $-1.39 | 6 |
| 2028-12-31 | $-1.61 | $-1.44 | $-1.25 | 3 |
| 2029-12-31 | $-2.07 | $-1.00 | $-0.04 | 1 |
| 2030-12-31 | $-0.55 | $-0.27 | $-0.01 | 1 |
Frequently Asked Questions
What is the analyst consensus for IMTX?
The consensus among 3 analysts covering Immatics N.V. (IMTX) is Buy with an average price target of $21.00.
What is the highest price target for IMTX?
The highest price target for IMTX is $28.00, set by Geulah Livshits at Chardan Capital on 2022-08-09.
What is the lowest price target for IMTX?
The lowest price target for IMTX is $16.00, set by Graig Suvannavejh at Mizuho Securities on 2024-05-16.
How many analysts cover IMTX?
3 analysts have issued ratings for Immatics N.V. in the past 12 months.
Is IMTX a buy or sell right now?
Based on 3 analyst ratings, IMTX has a consensus rating of Buy (2.00/5) with a +94.1% upside to the consensus target of $21.00.
What are the earnings estimates for IMTX?
Analysts estimate IMTX will report EPS of $-0.41 for the period ending 2026-06-30, with revenue estimated at $10M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.